Bregal Sagemount

The firm raises committed fund vehicles but retains the ability to access supplemental capital from Bregal Investments on a deal-specific basis. That means Sagemount can upsize a check or lead a larger round without syndication pressure, effectively blending closed-end discipline with evergreen balance-sheet capacity.

Bregal Sagemount operates as an independent growth-equity manager with its own investment committee and New York headquarters, but it was incubated by and remains an affiliate of Bregal Investments — the pan-European private capital platform seeded by the Brenninkmeijer family. The relationship provides access to patient capital and a European limited-partner network without dictating day-to-day investment decisions.

The firm targets $15 million to $150 million per investment. In addition, a dedicated small-cap program called Sagemount Technology Growth handles positions below $50 million, often for earlier-stage companies or smaller growth-equity rounds.

The primary geographic focus is the United States and Canada. Selected deal activity reaches into Western Europe, typically in connection with the broader Bregal Investments network, but the firm does not maintain a dedicated non-US investment team.

Managing Partner and founder Gene Yoon chairs the investment committee. Co-founders Dean Nelson and Daniel Kim serve as managing partners and share committee responsibilities, with sector leads bringing diligence recommendations to the full committee for final approval.

The firm relies on a thematic sector-mapping approach, tracking B2B software, healthcare IT, fintech, and digital-health sub-segments to build relationships with founders and management teams before a process launches. The Bregal Investments ecosystem also surfaces transatlantic introductions, although Sagemount maintains an independent origination team in New York.

The firm follows a standard private-equity partnership model: management fees on committed capital during the investment period, stepped down after, with carried interest payable after returning committed capital plus a preferred return. Specific hurdle rates and carry percentages are not publicly disclosed.